Cardiff Oncology, Inc. Common Stock CRDF
$0.96
-2.13%
at last close
Analyst Consensus
- Consensus Rating
- Hold (1 Buy · 4 Hold · 0 Sell)
- Average Price Target
- $4.00
- Implied Upside
- +315.4%
- Price Target Range
- $2.00 – $6.00
- Analysts (12 mo)
- 5
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-12 | William BlairAndy Hsieh |
Downgrades | Outperform → Market perform | — |
| 2026-06-03 | Craig-HallumAlbert Lowe |
Downgrades | Buy → Hold | $10 → $2 |
| 2026-06-01 | TD CowenMarc Frahm |
Downgrades | Buy → Hold | — |
| 2026-06-01 | HC Wainwright & Co.Robert Burns |
Downgrades | Buy → Neutral | — |
| 2026-02-25 | Piper SandlerEdward Tenthoff |
Maintains | Overweight | $10 → $6 |
| 2026-01-28 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $10 |
| 2025-08-06 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $18 → $10 |
| 2025-07-08 | Ladenburg ThalmannKevin DeGeeter |
Initiates coverage on | Buy | $19 |
| 2025-06-24 | JefferiesMaury Raycroft |
Initiates coverage on | Hold | $4 |
| 2025-05-09 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $17 → $18 |
| 2025-02-28 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $13 → $17 |
| 2024-12-13 | Piper SandlerJoseph Catanzaro |
Maintains | Overweight | $7 → $10 |
| 2024-11-08 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $14 → $13 |
| 2024-09-06 | Craig-HallumAlbert Lowe |
Initiates coverage on | Buy | $8 |
| 2024-05-06 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $14 |
| 2024-03-06 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $12 → $14 |
| 2024-03-01 | Piper SandlerJoseph Catanzaro |
Maintains | Overweight | $5 → $7 |
| 2023-08-11 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $13 → $12 |
| 2023-08-08 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $14 → $13 |
| 2023-05-09 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $15 → $14 |
| 2023-03-29 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $15 |
| 2023-03-07 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $14 → $15 |
| 2022-09-16 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $22 → $14 |
| 2022-09-13 | Piper SandlerJoseph Catanzaro |
Maintains | Overweight | $7 → $5 |
| 2022-08-29 | BairdJoel Beatty |
Maintains | Outperform | $9 → $6 |
| 2022-05-09 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $25 → $22 |
| 2022-02-28 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $26 → $25 |
| 2021-12-08 | BairdJoel Beatty |
Initiates coverage on | Outperform | $19 |
| 2021-08-10 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $25 → $26 |
| 2021-05-10 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $27 → $25 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $0.96
- Market Cap
- $77.06 million
- 52-Week Range
- $0.76 – $4.55
- Average Volume
- 1.42 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.